Literature DB >> 26645757

New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.

Elena Eliadou, Andrew S Day, Mark W Thompson-Fawcett, Richard B Gearry, David S Rowbotham, Russel Walmsley, Michael Schultz, Stephen J Inns1.   

Abstract

The management of patients with ulcerative colitis who are dependent on corticosteroid for control of symptoms, or refractory to corticosteroids or standard immunosuppressive therapy, is challenging. The development of newer medical therapies has increased the options for managing patients in this situation, but access and funding remain limited. This guideline summarises the literature regarding this situation and provides guidance as to the management of refractory colitis in the New Zealand setting.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26645757

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


  4 in total

1.  Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer.

Authors:  Fei Mao; Jing-Jing Kang; Xiu Cai; Ning-Feng Ding; Yun-Bing Wu; Yong-Min Yan; Hui Qian; Xu Zhang; Wen-Rong Xu
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30

2.  Patients' accounts of living with and managing inflammatory bowel disease in rural Southern New Zealand: a qualitative study.

Authors:  Lauralie Richard; Geoff Noller; Sarah Derrett; Trudy Sullivan; Fiona Doolan-Noble; Andrew McCombie; Michael Schultz; Christine Ho; Tim Stokes
Journal:  BMJ Open       Date:  2020-11-12       Impact factor: 2.692

3.  Is there a standardized practice for the development of international ulcerative colitis and Crohn's disease treatment guidelines?

Authors:  Alexander Goldowsky; Rohan Sen; Gila Hoffman; Joseph D Feuerstein
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-03-29

4.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.